Cargando…

What Is the Role of Body Composition Assessment in HCC Management?

SIMPLE SUMMARY: Recent advances in evaluating nutritional status showed that body mass index is an inaccurate tool for assessing nutritional status. Furthermore, emerging data suggest that the body composition may be used as a non-invasive clinical tool with prognostic value in patients with hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radu, Pompilia, Ebadi, Maryam, Montano-Loza, Aldo J., Dufour, Jean Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656561/ https://www.ncbi.nlm.nih.gov/pubmed/36358709 http://dx.doi.org/10.3390/cancers14215290

Ejemplares similares

Changing TACTICS in intermediate HCC: TACE plus sorafenib
por: Radu, Pompilia, et al.
Publicado: (2020)

Perspective: improving vitamin D status in the management of COVID-19
por: Ebadi, Maryam, et al.
Publicado: (2020)

Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies
por: Ebadi, Maryam, et al.
Publicado: (2021)

Sarcopenia in cirrhosis: from pathogenesis to interventions
por: Ebadi, Maryam, et al.
Publicado: (2019)

Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib
por: Moser, Monika, et al.
Publicado: (2021)

Reliable Measures of Sarcopenia in Cirrhosis. Comment on: “The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097”
por: Ebadi, Maryam, et al.
Publicado: (2020)

Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?
por: Wasilenko, Shawn T., et al.
Publicado: (2013)

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
por: Emamaullee, Juliet A., et al.
Publicado: (2019)

Should we undertake surveillance for HCC in patients with MAFLD?
por: Norero, Blanca, et al.
Publicado: (2023)

Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
por: Sparchez, Zeno, et al.
Publicado: (2021)

Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions
por: Ebadi, Maryam, et al.
Publicado: (2022)

Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2023)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Assessment of body composition by whole-body densitometry: what radiologists should know
por: Chaves, Lucas Gabriel Cruz de Menezes, et al.
Publicado: (2022)

Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2020)

Comparison of the current international guidelines on the management of HCC
por: Foerster, Friedrich, et al.
Publicado: (2019)

A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
por: Eldafashi, Nardeen, et al.
Publicado: (2021)

Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
por: Rusu, Ioana, et al.
Publicado: (2022)

Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2018)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

Advanced body composition assessment: from body mass index to body composition profiling
por: Borga, Magnus, et al.
Publicado: (2018)

The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC
por: Granata, Vincenza, et al.
Publicado: (2018)

Immunotherapy and Transarterial therapy of HCC: What the interventional radiologist needs to know about the changing landscape of HCC treatment?
por: Tibballs, Jonathan, et al.
Publicado: (2022)

Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective
por: Montano‐Loza, Aldo J., et al.
Publicado: (2017)

Roles of circRNAs in the Tumorigenesis and Metastasis of HCC: A Mini Review
por: Liu, Yichen, et al.
Publicado: (2022)

The Epigenetic Regulation of HCC Metastasis
por: Han, Tae-Su, et al.
Publicado: (2018)

Inflammatory Mechanisms of HCC Development
por: Refolo, Maria Grazia, et al.
Publicado: (2020)

Diabetes medications and risk of HCC
por: Plaz Torres, Maria Corina, et al.
Publicado: (2022)

Basal body structure and composition in the apicomplexans Toxoplasma and Plasmodium
por: Francia, Maria E., et al.
Publicado: (2016)

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
por: Iezzi, Roberto, et al.
Publicado: (2023)

Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022)

A226 SEX-BASED DISPARITY COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION
por: Singh, N, et al.
Publicado: (2022)

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
por: Luo, Laihui, et al.
Publicado: (2022)

The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases
por: Gabbia, Daniela, et al.
Publicado: (2021)

The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy
por: Ebadi, Maryam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l48vidqjnmbihskkkr7q8m8lh5